Related Experiment Videos
TLK1B is elevated with eIF4E overexpression in breast cancer
Kathryn S Norton1, Derek McClusky, Siddhartha Sen
1Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.
The Journal of Surgical Research
|January 21, 2004
Summary
Eukaryotic initiation factor 4E (eIF4E) and Tousled-like kinase 1B (TLK1B) are elevated in breast cancer. TLK1B elevation correlates with eIF4E overexpression, independent of tumor characteristics.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Eukaryotic initiation factor 4E (eIF4E) overexpression is linked to malignant transformation and breast cancer recurrence.
- Dysregulation of Tousled-like kinase 1B (TLK1B) is associated with cell division defects and radiation resistance.
- The hypothesis posits a correlation between TLK1B elevation and eIF4E overexpression in human breast carcinoma.
Purpose of the Study:
- To investigate the correlation between TLK1B elevation and eIF4E overexpression in human breast carcinoma.
- To determine if TLK1B and eIF4E levels are elevated in breast cancer specimens compared to benign breast tissue.
- To assess the independence of TLK1B and eIF4E overexpression from clinical and pathological tumor features.
Main Methods:
- Prospective accrual of 87 invasive breast cancer patients and 11 patients with benign breast disease.
- Quantification of TLK1B and eIF4E protein levels using Western blot analysis.
- Statistical analysis including Spearman correlation and multivariate analysis to assess relationships and independence.
Main Results:
- Both eIF4E and TLK1B were significantly elevated in breast cancer specimens compared to benign breast tissue (mean 9.5-fold and 9.4-fold increase, respectively).
- Multivariate analysis confirmed that the overexpression of both eIF4E and TLK1B were independent of patient age, race, tumor grade, and ER/PR status.
- A strong positive correlation was observed between the degree of TLK1B elevation and eIF4E overexpression (r = 0.39, P = 0.001).
Conclusions:
- Both eIF4E and TLK1B are significantly elevated in breast cancer.
- The degree of TLK1B elevation is strongly correlated with the degree of eIF4E overexpression in breast cancer.
- Overexpression of eIF4E and TLK1B in breast cancer is independent of tumor grade, stage, and hormone receptor status.